Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why HEXO Stock is Starting to Look Attractive at These Levels

By Chris Lau, InvestorPlace Contributor

Hexo stock is in danger of trending lower. Cannabis companies are out of favor, pressuring Hexo to start generating sales.

Investors Should Still Consider Square Stock

By Chris Lau, InvestorPlace Contributor

Buying momentum in SQ stock faded in recent months. As investments in the company pay off, revenue growth will accelerate.

Believe It or Not, Nio Stock Still Has a Good Chance to Move Higher

By Chris Lau, InvestorPlace Contributor

Nio held up after announcing spending cuts and a debt issuance to raise its cash levels. Prospects over the long-term look better.

Look for Microsoft Stock to See a Big Post-Earnings Pop

By Chris Lau, InvestorPlace Contributor

Microsoft's rally paused in recent weeks, but the breather is likely to end. Once earnings are reported Microsoft stock should get a boost.

Avoid Aurora Cannabis Stock Until Investor Fears Subside

By Chris Lau, InvestorPlace Contributor

Aurora Cannabis stock is in a downtrend that it cannot shake off. Strong fourth-quarter revenue numbers failed to impress. What's next?

Load More